A single-dose of an Ebola vaccine given to primates through their noses and lungs protected them against infection for at least 21 weeks.

FTA:

Scientists have demonstrated for the first time that a single-dose, needleless Ebola vaccine given to primates through their noses and lungs protected them against infection for at least 21 weeks.